1. Detection of HIV-1 and Human Proteins in Urinary Extracellular Vesicles from HIV+ Patients
    Samuel I. Anyanwu et al, 2018, Advances in Virology CrossRef
  2. Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma
    Hiroe Tada et al, 2020, Scientific Reports CrossRef
  3. Current therapeutic modalities and chemopreventive role of natural products in liver cancer: Progress and promise
    Amit Kumar Singh et al, 2023, World Journal of Hepatology CrossRef
  4. Targeting the cMET pathway to enhance immunotherapeutic approaches for mUM patients
    Devayani Machiraju et al, 2023, Frontiers in Oncology CrossRef
  5. The Emerging Role of the c-MET-HGF Axis in Non-small Cell Lung Cancer Tumor Immunology and Immunotherapy
    Helen F. Titmarsh et al, 2020, Frontiers in Oncology CrossRef
  6. Impairing energy metabolism in solid tumors through agents targeting oncogenic signaling pathways
    Claudia Fumarola et al, 2018, Biochemical Pharmacology CrossRef
  7. Indoleamine 2,3-Dioxygenase Activity-Induced Acceleration of Tumor Growth, and Protein Kinases-Related Novel Therapeutics Regimens
    Ayse Basak Engin et al, 2021, Protein Kinase-mediated Decisions Between Life and Death CrossRef
  8. How Signaling Molecules Regulate Tumor Microenvironment: Parallels to Wound Repair
    Peter Gál et al, 2017, Molecules CrossRef
  9. New Therapeutic Options for Advanced Hepatocellular Carcinoma
    Yu-Shui Ma et al, 2020, Cancer Control CrossRef

  10. Preparation, Characterization, and in vivo Evaluation of NK4-Conjugated Hydroxycamptothecin-Loaded Liposomes


    Ting Zhou et al, 2020, International Journal of Nanomedicine CrossRef
  11. Evolving therapeutic landscape of advanced hepatocellular carcinoma
    Chen Yang et al, 2023, Nature Reviews Gastroenterology & Hepatology CrossRef
  12. A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer
    Melinda A Pruis et al, 2023, The Oncologist CrossRef
  13. Highlights on selected growth factors and their receptors as promising anticancer drug targets
    Mohammed A. Mansour et al, 2021, The International Journal of Biochemistry & Cell Biology CrossRef
  14. Astragaloside IV Inhibits the Proliferation of Human Uterine Leiomyomas by Targeting IDO1
    Tiantian Qiu et al, 2022, Cancers CrossRef
  15. Targeting micro-environmental pathways by PROTACs as a therapeutic strategy
    Jing Liu et al, 2022, Seminars in Cancer Biology CrossRef
  16. Emerging trends in gastrointestinal cancers: Targeting developmental pathways in carcinogenesis and tumor progression
    Afza Ahmad et al, 2024, Targeting Signaling Pathways in Solid Tumors - Part A CrossRef